Adults with ADHD do appear to have a higher risk of developing dementia later in life. Large population studies have found the risk is roughly two to three times greater than for adults without ADHD, though the connection is more nuanced than that headline number suggests. The type of dementia matters, psychiatric comorbidities play a significant role, and the overlap in symptoms between the two conditions makes the relationship harder to untangle than it first appears.
What the Largest Studies Show
Two major cohort studies have shaped the current understanding of ADHD and dementia risk. A Swedish study of 3.6 million people found that adults with ADHD had nearly three times the risk of developing dementia compared to those without ADHD. They also had a six-fold higher risk of mild cognitive impairment, the stage of noticeable memory and thinking problems that often precedes dementia. However, when researchers accounted for co-occurring psychiatric conditions like depression, anxiety, and substance use disorders, the dementia risk dropped to about 1.6 times higher, and the mild cognitive impairment risk dropped to about 2.5 times higher. That adjustment matters: it suggests a meaningful portion of the elevated risk comes not from ADHD itself but from the conditions that frequently accompany it.
A 2023 Israeli cohort study published in JAMA Network Open followed more than 109,000 adults aged 51 to 70 for up to 17 years. After adjusting for 18 potential confounding factors, adults who developed ADHD in adulthood still had a 2.77-fold increased risk of dementia. That’s a substantial elevation even after rigorous statistical controls, and it reinforced the finding that the link isn’t just a statistical artifact of poor health habits or co-occurring mental illness.
The Link Is Strongest for Lewy Body Dementia
Not all dementias carry the same association with ADHD. The strongest evidence points specifically toward Lewy body dementia, a condition caused by abnormal protein deposits in the brain that affects thinking, movement, behavior, and mood. One study found that nearly 48% of people with Lewy body dementia had a history of ADHD, compared to about 15% of people with Alzheimer’s disease and 15% of healthy controls. People with ADHD were roughly five times more likely to develop Lewy body dementia than those without it.
The connection to Alzheimer’s disease, by contrast, is weak or nonexistent. One analysis found no statistically significant increased risk of Alzheimer’s specifically in people with ADHD. This distinction is important because Alzheimer’s is the most common form of dementia, and the fact that ADHD doesn’t appear to raise that particular risk helps narrow down what biological pathways might be involved.
Why Dopamine May Be the Common Thread
Both ADHD and Lewy body dementia involve disruptions to the brain’s dopamine system. In ADHD, dopamine signaling in the prefrontal cortex is impaired, which is why stimulant medications that boost dopamine activity help with focus and impulse control. Lewy body dementia also heavily involves dopamine-producing neurons, which is part of why it shares motor symptoms with Parkinson’s disease (another dopamine-related condition).
Dopamine does more than regulate attention and movement. It plays a central role in neuroplasticity, the brain’s ability to strengthen or reorganize neural connections over time. When dopamine signaling is chronically disrupted, the brain’s capacity to adapt and maintain healthy circuits may erode more quickly with aging. This could help explain why a lifetime of altered dopamine function in ADHD might leave the brain more vulnerable to certain types of neurodegeneration, particularly those that target the same chemical pathways.
Genetic Overlap
Genetic studies add another layer. Researchers have calculated polygenic risk scores for ADHD, essentially a measure of how many ADHD-associated gene variants a person carries, and tested whether those scores predict anything about dementia. People with higher ADHD genetic risk who went on to develop dementia showed worse executive function, higher levels of a protein called phosphorylated tau in their spinal fluid (a hallmark of neurodegeneration), and reduced brain energy metabolism in the frontal and parietal cortices. Notably, there was no association with amyloid beta, the protein most closely linked to Alzheimer’s. This genetic evidence aligns with the clinical finding that the ADHD-dementia link is specific to certain types of brain degeneration rather than a blanket risk for all cognitive decline.
ADHD Symptoms Can Mimic Early Dementia
One major complication in studying this relationship is that ADHD and early-stage dementia look similar on the surface. Difficulty sustaining attention, trouble organizing tasks, forgetfulness, poor multitasking: these are core features of ADHD, but they’re also the hallmarks of mild cognitive impairment. In adults over 50, this overlap creates real diagnostic confusion. Some people diagnosed with early dementia may actually have unrecognized lifelong ADHD, and some people with ADHD may receive unnecessary dementia workups.
Clinicians can often tell the two apart with a careful history. The most important clue is timing. ADHD symptoms begin in childhood, even if they weren’t formally diagnosed until adulthood. People with ADHD can typically give a detailed, coherent account of their difficulties and describe a pattern that has been consistent for decades. People with early dementia, on the other hand, usually describe a recent and noticeable worsening. They may struggle to provide a detailed history precisely because memory difficulties are part of the problem. Another distinguishing feature: medications designed for dementia, such as cholinesterase inhibitors, have no effect on ADHD symptoms, which further supports the idea that the underlying brain changes are fundamentally different even when the surface symptoms look alike.
This diagnostic overlap also raises an important question about the research itself. Some of the elevated dementia risk seen in ADHD populations could reflect misdiagnosis, where early dementia symptoms are initially coded as ADHD, artificially inflating the apparent connection. Researchers have tried to control for this by excluding people who received both diagnoses within a short time window, but it remains a limitation.
Could ADHD Medication Lower Dementia Risk?
There is early evidence that stimulant medications used to treat ADHD may reduce dementia risk. Because stimulants work by increasing dopamine availability in the brain, long-term use could theoretically help compensate for the dopamine-related vulnerabilities that link ADHD to neurodegeneration. The data on this is still preliminary, and no randomized trial has tested it directly. But the possibility that treating ADHD could have a protective effect on long-term brain health is one of the more promising angles in this area of research.
What This Means in Practical Terms
An elevated relative risk of two to three times sounds alarming, but context matters. Dementia is relatively uncommon before age 65, and even a tripled risk of a low-probability event is still a low-probability event for any individual. The absolute risk increase for a given person with ADHD is modest, especially in middle age. The risk is also significantly reduced once co-occurring conditions like depression, anxiety, and substance use are managed, which means that treating the full picture of ADHD, not just inattention, likely matters for long-term cognitive health.
If you have ADHD and are concerned about cognitive decline, the same strategies that protect brain health in the general population apply with extra relevance: regular physical activity, consistent sleep, treatment of depression and anxiety, and staying socially and intellectually engaged. The specific link to Lewy body dementia rather than Alzheimer’s also suggests that maintaining dopamine system health through exercise (which reliably boosts dopamine signaling) may be particularly valuable for people with ADHD as they age.